Insu Therapeutics
Company

Insu Therapeutics

Biotechnology Research 6 employees
Employees
6

Insu Therapeutics Overview

Industry
Biotechnology Research
Employees
6
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Insu Therapeutics

Insu Therapeutics is redefining diabetes treatment with a groundbreaking non-invasive insulin delivery technology, to relieve the discomfort of traditional injections and enhance patient experiences for over 9 million type 1 diabetics and the broader needs of over half a billion people with diabetes globally.

Compare Similar Companies to Insu Therapeutics